Xvivo Perfusion ABXVIPF 91 Degree of Operating Leverage is 0.95 as of Mar. 2026. GuruFocus rates XVIPF with a GF Score™ of 91/100 and a GF Value™ of $41.85 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Xvivo Perfusion AB ranks worse than 57.74% on this metric.
Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue.
Xvivo Perfusion AB's Degree of Operating Leverage for the quarter that ended in Mar. 2026 was 0.95. The higher Degree of Operating Leverage, the higher operating risk the company will take.
The industry rank for Xvivo Perfusion AB's Degree of Operating Leverage or its related term are showing as below:
XVIPF's Degree of Operating Leverage is ranked worse than 57.74% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 0.235
vs XVIPF: 0.95
Xvivo Perfusion AB (OTCPK:XVIPF) Degree of Operating Leverage Explanation
Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.
A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.
Be Aware
The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.
Xvivo Perfusion AB Degree of Operating Leverage Related Terms
Xvivo Perfusion AB Degree of Operating Leverage Historical Data
* Premium members only.
The historical data trend for Xvivo Perfusion AB's Degree of Operating Leverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xvivo Perfusion AB Degree of Operating Leverage Chart
XVIPF vs ABT, SYK, MDT: Degree of Operating Leverage Comparison
For the Medical Devices subindustry, Xvivo Perfusion AB's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xvivo Perfusion AB Degree of Operating Leverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's Degree of Operating Leverage distribution charts can be found below:
* The bar in red indicates where Xvivo Perfusion AB's Degree of Operating Leverage falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
What does a Degree of Operating Leverage of 0.95 mean?
Xvivo Perfusion AB (XVIPF) has a Degree of Operating Leverage of 0.95 as of Mar. 2026. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for Xvivo Perfusion AB and its competitors. According to the industry distribution chart, Xvivo Perfusion AB ranks #455 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 57.7%.
Is Xvivo Perfusion AB's Degree of Operating Leverage too high?
Xvivo Perfusion AB's current Degree of Operating Leverage is 0.95. The Medical Devices & Instruments industry median Degree of Operating Leverage is 0.24. Xvivo Perfusion AB's value of 0.95 is 304.3% above this industry median. Based on the distribution chart, Xvivo Perfusion AB ranks #455 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Xvivo Perfusion AB has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Xvivo Perfusion AB's Degree of Operating Leverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Xvivo Perfusion AB ranks #455 out of 788 companies for Degree of Operating Leverage. This places Xvivo Perfusion AB in the lower half of its industry. The industry median Degree of Operating Leverage is 0.24. Xvivo Perfusion AB's value of 0.95 is 304.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Degree of Operating Leverage for a Medical Devices & Instruments company?
The median Degree of Operating Leverage among Medical Devices & Instruments companies is 0.24, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Degree of Operating Leverage significantly above this median, while those in the bottom quartile fall well below. However, Degree of Operating Leverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xvivo Perfusion AB's current Degree of Operating Leverage of 0.95 is 304.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Degree of Operating Leverage mean?
A high Degree of Operating Leverage can signal that a stock is expensive relative to its fundamentals. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for Xvivo Perfusion AB and its competitors. For the Medical Devices & Instruments industry, the median Degree of Operating Leverage is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xvivo Perfusion AB's current Degree of Operating Leverage is 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xvivo Perfusion AB stock overvalued right now?
Based on GuruFocus' analysis, Xvivo Perfusion AB (XVIPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $41.85, compared to a current price of $29.48 — trading 29.6% below its estimated fair value. The current Degree of Operating Leverage is 0.95 and 304.3% above the Medical Devices & Instruments industry median of 0.24. Xvivo Perfusion AB's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Degree of Operating Leverage calculated?
Degree of Operating Leverage is calculated from a company's financial statements. For Xvivo Perfusion AB (XVIPF), the current Degree of Operating Leverage is 0.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xvivo Perfusion AB (XVIPF) Overvalued in 2026?
Based on GuruFocus' analysis, Xvivo Perfusion AB stock appears to be undervalued.
The current stock price of $29.48 is trading 29.6% below its estimated GF Value™ of $41.85.
GuruFocus considers Xvivo Perfusion AB to be Significantly Undervalued.
Key valuation signals for XVIPF:
Degree of Operating Leverage: 0.95
GF Value™: $41.85 vs. price of $29.48 (29.6% below fair value)
Industry Position: 304.3% above the Medical Devices & Instruments median (#455 of 788)
No single metric tells the full story. See the XVIPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments, namely Thoracic: sales of lung and heart transplant products; Abdominal: sales of liver and kidney transplant products and perfusion services; and Services: revenue from the sale of services related to organ recovery, as well as digital products for communication and workflow management at transplantation clinics. The majority of revenue is derived from the Thoracic segment, and geographically, the majority is from the United States.
91GF Score
Get the complete analysis for XVIPF
Degree of Operating Leverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XVIPF has been successfully added to your 
